Literature DB >> 22522070

Control of phonatory onset and offset in Parkinson patients following deep brain stimulation of the subthalamic nucleus and caudal zona incerta.

Fredrik Karlsson1, Patric Blomstedt, Katarina Olofsson, Jan Linder, Erik Nordh, Jan van Doorn.   

Abstract

Laryngeal hypokinesia is a common symptom in Parkinson's disease (PD) that affects quality of life. Deep brain stimulation (DBS) is well recognized as a complementary method for treatment of motor symptoms in PD but the outcomes on patients' control over phonatory alternation have yet not been clearly elucidated. The present study examined the effect of subthalamic nucleus STN-DBS (n = 8, aged 51-72 yrs; median = 63 yrs) and caudal Zona incerta cZi-DBS (n = 8, aged 49-71 yrs; median = 61 yrs) on control of onset and offset of phonation in connected speech. The patients were evaluated in a preoperatively (Med ON, 1.5 times the ordinary Levodopa dose) and 12 months post-operatively (Med ON, ordinary Levodopa dose). The results provided evidence of a progressive reduction in the ability to manifest alternations between voicing and voiceless states in a reading task. Mean proportion produced with inappropriate voicing increased from 47.6% to 55.3% and from 62.9% to 68.6% of the total duration for the two groups of patients between Pre-op and Post-op, Stim OFF evaluations. The medial and final parts of the fricative were more affected than the initial part, indicating an increased voicing lead into the following vowel. We propose that this reduction in phonatory control is be due to either progression of the disease, an effect of reduced Levodopa dosage or a microlesional effect. Patients' proficiency in alternating between voiced and voiceless states in connected speech remained unaffected by both STN-DBS and cZi-DBS.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22522070     DOI: 10.1016/j.parkreldis.2012.03.025

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

1.  Speech-induced striatal dopamine release is left lateralized and coupled to functional striatal circuits in healthy humans: a combined PET, fMRI and DTI study.

Authors:  Kristina Simonyan; Peter Herscovitch; Barry Horwitz
Journal:  Neuroimage       Date:  2012-12-28       Impact factor: 6.556

2.  Characteristic laryngoscopic findings in Parkinson's disease patients after subthalamic nucleus deep brain stimulation and its correlation with voice disorder.

Authors:  Takashi Tsuboi; Hirohisa Watanabe; Yasuhiro Tanaka; Reiko Ohdake; Noritaka Yoneyama; Kazuhiro Hara; Mizuki Ito; Masaaki Hirayama; Masahiko Yamamoto; Yasushi Fujimoto; Yasukazu Kajita; Toshihiko Wakabayashi; Gen Sobue
Journal:  J Neural Transm (Vienna)       Date:  2015-08-09       Impact factor: 3.575

3.  Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation.

Authors:  Linda Sandström; Patricia Hägglund; Louise Johansson; Patric Blomstedt; Fredrik Karlsson
Journal:  Brain Behav       Date:  2015-09-25       Impact factor: 2.708

4.  Effect of subthalamic stimulation on voice and speech in Parkinson's disease: for the better or worse?

Authors:  Sabine Skodda; Wenke Grönheit; Uwe Schlegel; Martin Südmeyer; Alfons Schnitzler; Lars Wojtecki
Journal:  Front Neurol       Date:  2014-01-13       Impact factor: 4.003

5.  Effect of deep brain stimulation on speech performance in Parkinson's disease.

Authors:  Sabine Skodda
Journal:  Parkinsons Dis       Date:  2012-11-21

6.  The Feasibility of Using Acoustic Markers of Speech for Optimizing Patient Outcomes during Randomized Amplitude Variation in Deep Brain Stimulation: A Proof of Principle Methods Study.

Authors:  Adam P Vogel; Hugh J McDermott; Thushara Perera; Mary Jones; Richard Peppard; Colette M McKay
Journal:  Front Bioeng Biotechnol       Date:  2015-07-14

7.  Subcortical Effects on Voice and Fluency in Dysarthria: Observations from Subthalamic Nucleus Stimulation.

Authors:  Diana Sidtis; John J Sidtis
Journal:  J Alzheimers Dis Parkinsonism       Date:  2017-10-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.